| 产品详情 |
| Edit |   |
|---|
| Product Name | Recombinant Rat Nanos homolog 3 protein |
|---|
| Description | 519-690aa; Partial. MW: 23kD. Purity >90% as determined by SDS-PAGE. Produces nitric oxide (NO) which is implicated in vascular smooth muscle relaxation through a cGMP-mediated signal transduction pathway. NO mediates vascular endothelial growth factor (VEGF)-induced angiogenesis in coronary vessels and promotes blood clotting through the activation of platelets. |
|---|
| Size | 0.01 mg, 0.05 mg, 0.1 mg, 0.2 mg, 0.5 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | [Constitutive NOS; cNO; SEC-NOS; Endothelial NOS; eNOS; NOS type III; NOSIII] |
|---|
| Gene, Accession, CAS # | Nos3, Gene ID: 24600, Accession: NP_068610.1 |
|---|
| Catalog # | MBS1265277 |
|---|
| Price | |
|---|
| Order / More Info | Recombinant Rat Nanos homolog 3 protein from MYBIOSOURCE INC. |
|---|
| Product Specific References | NIDD, a novel DHHC-containing protein, targets neuronal nitric-oxide synthase (nNOS) to the synaptic membrane through a PDZ-dependent interaction and regulates nNOS activity.Saitoh F., Tian Q.B., Okano A., Sakagami H., Kondo H., Suzuki T.J. Biol. Chem. 279:29461-29468(2004) Downregulation of endothelial nitric oxide synthase (NOS III) in rat aorta following in-vivo hypoxia.Toporsian M., Govindaraju K., Nagi M., Eidelman D., Thibault G., Ward M.E. Increased resistance to myocardial ischemia in th |
|---|
| 产品资料 |
|
|